These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32282308)

  • 1. Assessment of the Efficacy of
    Fuladi S; Emami SA; Mohammadpour AH; Karimani A; Manteghi AA; Sahebkar A
    Curr Rev Clin Exp Pharmacol; 2021; 16(2):191-196. PubMed ID: 32282308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: A randomized double-blind placebo-controlled trial.
    Jahanbakhsh SP; Manteghi AA; Emami SA; Mahyari S; Gholampour B; Mohammadpour AH; Sahebkar A
    Complement Ther Med; 2016 Aug; 27():25-9. PubMed ID: 27515872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder.
    Amsterdam JD; Li Y; Soeller I; Rockwell K; Mao JJ; Shults J
    J Clin Psychopharmacol; 2009 Aug; 29(4):378-82. PubMed ID: 19593179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Simvastatin as Augmentative Therapy in the Treatment of Generalized Anxiety Disorder: A Pilot Randomized, Placebo-Controlled Study.
    Mirzaei E; Mirjalili M; Jahangard L; Haghighi M; Yasrebifar F; Mohammadi Y; Larki-Harchagani A; Mehrpooya M
    Neuropsychobiology; 2021; 80(3):242-252. PubMed ID: 33070132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD).
    Cutler NR; Sramek JJ; Macpherson AE; Doss MG; Benes CO; Howard SF
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):685-94. PubMed ID: 7938559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of Shu-gan-qing-re formula for generalized anxiety disorder: study protocol for a multi-center, prospective, double-blind, double-dummy, randomized controlled trial.
    Chen P; Zhu H; Ning Y; Yin D; Jia H
    Trials; 2020 Mar; 21(1):266. PubMed ID: 32171323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
    Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
    J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Standardized
    Majeed M; Nagabhushanam K; Murali A; Vishwanathan DT; Mamidala RV; Mundkur L
    J Integr Complement Med; 2024 May; 30(5):459-468. PubMed ID: 37878284
    [No Abstract]   [Full Text] [Related]  

  • 10. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study.
    Lopresti AL; Smith SJ; Malvi H; Kodgule R
    Medicine (Baltimore); 2019 Sep; 98(37):e17186. PubMed ID: 31517876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled evaluation of the anxiolytic efficacy ff an ethanolic extract of withania somnifera.
    Andrade C; Aswath A; Chaturvedi SK; Srinivasa M; Raguram R
    Indian J Psychiatry; 2000 Jul; 42(3):295-301. PubMed ID: 21407960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putative Antidepressant Effect of Chamomile (
    Amsterdam JD; Li QS; Xie SX; Mao JJ
    J Altern Complement Med; 2020 Sep; 26(9):813-819. PubMed ID: 31808709
    [No Abstract]   [Full Text] [Related]  

  • 15. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
    Carter NJ; McCormack PL
    CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder.
    Keefe JR; Mao JJ; Soeller I; Li QS; Amsterdam JD
    Phytomedicine; 2016 Dec; 23(14):1699-1705. PubMed ID: 27912871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.
    Savage KM; Stough CK; Byrne GJ; Scholey A; Bousman C; Murphy J; Macdonald P; Suo C; Hughes M; Thomas S; Teschke R; Xing C; Sarris J
    Trials; 2015 Nov; 16():493. PubMed ID: 26527536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder.
    Chengappa KN; Bowie CR; Schlicht PJ; Fleet D; Brar JS; Jindal R
    J Clin Psychiatry; 2013 Nov; 74(11):1076-83. PubMed ID: 24330893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study.
    Langade D; Kanchi S; Salve J; Debnath K; Ambegaokar D
    Cureus; 2019 Sep; 11(9):e5797. PubMed ID: 31728244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study.
    Llorca PM; Spadone C; Sol O; Danniau A; Bougerol T; Corruble E; Faruch M; Macher JP; Sermet E; Servant D
    J Clin Psychiatry; 2002 Nov; 63(11):1020-7. PubMed ID: 12444816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.